Building speciality portfolio of around 150 products in next 3 fiscal yrs: Aurobindo

In a regulatory filing to BSE, the company said 79 products are under development in oncology and hormones, 22 are in topicals, 5 are in nasals, 14 are in peptides and 4 in depot injection segment.

Original source:

Related Posts